Furthermore, treatment of tumor bearing animals with myeloid targeting agents enhanced CXCR3-mediated tumor homing resulting in improved survival21,22, highlighting the critical role of CXCR3 mediated T cell chemotaxis as a common pathway to effective anti-tumor immunity. This evidence concerns the gene CXCR3 and neoplasm.